Aliases & Classifications for Blepharitis

Summaries for Blepharitis

Disease Ontology : 12 An eyelid disease that is characterized by often chronic inflammation of the eyelid, generally the part where eyelashes grow.

MalaCards based summary : Blepharitis is related to keratosis follicularis spinulosa decalvans, x-linked and blepharoconjunctivitis, and has symptoms including erythema of the eyelids An important gene associated with Blepharitis is MMP9 (Matrix Metallopeptidase 9), and among its related pathways/superpathways are IL-17 Family Signaling Pathways and Protein processing in endoplasmic reticulum. The drugs Hyaluronic acid and Ephedrine have been mentioned in the context of this disorder. Affiliated tissues include eye, skin and testes.

Wikipedia : 72 Blepharitis (/blɛfəˈraɪtɪs/ BLEF-ər-EYE-tis) is one of the most common ocular conditions characterized... more...

Related Diseases for Blepharitis

Diseases related to Blepharitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 82)
# Related Disease Score Top Affiliating Genes
1 keratosis follicularis spinulosa decalvans, x-linked 32.2 MBTPS2 SAT1
2 blepharoconjunctivitis 31.8 CCL11 IL4 SHE
3 conjunctivitis 30.3 CCL11 IL4
4 papillary conjunctivitis 29.8 CCL11 IL4
5 giant papillary conjunctivitis 29.8 CCL11 IL4
6 folliculitis 29.7 CCL11 IL4
7 keratoconjunctivitis 29.4 CCL11 IL4
8 ulcerative blepharitis 12.1
9 squamous blepharitis 12.1
10 ichthyosis, congenital, autosomal recessive 11 10.9
11 hordeolum externum 10.9
12 eyelid disease 10.9
13 meibomian cyst 10.9
14 keratosis follicularis spinulosa decalvans 10.4 MBTPS2 SAT1
15 corneal degeneration 10.4 MBTPS2 SAT1
16 chronic meningitis 10.3 CCL11 MMP9
17 corneal ulcer 10.3 CCL11 MMP9
18 scleritis 10.2 IL4 MMP9
19 hair disease 10.2 MBTPS2 SAT1
20 chromoblastomycosis 10.2 IL4 MMP9
21 strongyloidiasis 10.2 CCL11 SHE
22 gastrointestinal allergy 10.2 CCL11 IL4
23 chronic conjunctivitis 10.1 CCL11 IL4
24 eosinophilic gastritis 10.1 CCL11 IL4
25 kimura disease 10.1 CCL11 IL4
26 conjunctival disease 10.1 CCL11 IL4
27 pulmonary eosinophilia 10.1 CCL11 IL4
28 secondary progressive multiple sclerosis 10.1 IL4 MMP9
29 onchocerciasis 10.1 CCL11 IL4
30 herpes simplex 10.1
31 allergic conjunctivitis 10.1 CCL11 IL4
32 nasal cavity disease 10.1 CCL11 IL4
33 dermatitis herpetiformis 10.1 CCL11 IL4
34 lupus erythematosus 10.1
35 nose disease 10.1 CCL11 IL4
36 rosacea 10.0
37 discoid lupus erythematosus 10.0
38 upper respiratory tract disease 10.0 CCL11 IL4
39 leukocyte disease 10.0 CCL11 IL4
40 angiostrongyliasis 10.0 CCL11 IL4 MMP9
41 eosinophilic meningitis 10.0 CCL11 IL4 MMP9
42 vernal keratoconjunctivitis 10.0 CCL11 IL4 MMP9
43 respiratory system disease 10.0 CCL11 IL4 MMP9
44 keratitis, hereditary 9.9
45 dermatitis 9.9
46 gingivitis 9.9 IL4 MMP9
47 phlyctenulosis 9.8
48 autoimmune disease 9.7
49 blood group, i system 9.7
50 systemic lupus erythematosus 9.7

Comorbidity relations with Blepharitis via Phenotypic Disease Network (PDN):


Acute Cystitis Conjunctivitis
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Parkinson Disease, Late-Onset Schizophreniform Disorder

Graphical network of the top 20 diseases related to Blepharitis:



Diseases related to Blepharitis

Symptoms & Phenotypes for Blepharitis

UMLS symptoms related to Blepharitis:


erythema of the eyelids

Drugs & Therapeutics for Blepharitis

Drugs for Blepharitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 106)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
2
Ephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 299-42-3 9294
3
Acitretin Approved Phase 4 55079-83-9 5284513 6437841
4
Pseudoephedrine Approved Phase 4,Phase 3,Phase 1,Phase 2 90-82-4 7028
5
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
6
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
7
Glycerol Approved, Investigational Phase 4 56-81-5 753
8
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 53477736 447043 55185
9
Tobramycin Approved, Investigational Phase 4,Phase 3 32986-56-4 36294 5496
10
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
11
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
12
Loteprednol Approved Phase 4,Phase 3,Phase 2 129260-79-3, 82034-46-6 9865442 444025
13
Dipivefrin Approved Phase 4,Phase 3 52365-63-6 3105
14
Chloramphenicol Approved, Vet_approved Phase 4 56-75-7 5959 298
15
Formaldehyde Approved, Vet_approved Phase 4 50-00-0 712
16
Permethrin Approved, Investigational Phase 4 52645-53-1 40326
17
Fusidic Acid Approved, Investigational Phase 4 6990-06-3 3000226
18
Chloramphenicol succinate Experimental Phase 4 3544-94-3
19 Respiratory System Agents Phase 4,Phase 3,Phase 1,Phase 2
20 Adjuvants, Immunologic Phase 4
21 Nasal Decongestants Phase 4,Phase 3,Phase 1,Phase 2
22 Tetrahydrozoline Phase 4,Phase 3,Phase 1,Phase 2
23 Vasoconstrictor Agents Phase 4,Phase 3,Phase 1,Phase 2
24 Viscosupplements Phase 4
25 Dermatologic Agents Phase 4
26 Ophthalmic Solutions Phase 4,Phase 3,Phase 1,Phase 2
27 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2
28 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2
29 Protective Agents Phase 4
30 Keratolytic Agents Phase 4
31 Autonomic Agents Phase 4,Phase 3,Phase 1,Phase 2
32 Dexamethasone acetate Phase 4,Phase 3,Phase 2 1177-87-3
33 glucocorticoids Phase 4,Phase 3,Phase 2
34
protease inhibitors Phase 4,Phase 3,Phase 2
35 Cathartics Phase 4,Phase 3
36 Gastrointestinal Agents Phase 4,Phase 3,Phase 2
37 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2
38 Hormone Antagonists Phase 4,Phase 3,Phase 2
39 Hormones Phase 4,Phase 3,Phase 2
40 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
41 Anti-Allergic Agents Phase 4,Phase 3,Phase 2
42 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
43 Erythromycin Estolate Phase 4
44 Erythromycin Ethylsuccinate Phase 4
45 Erythromycin stearate Phase 4
46 Antiemetics Phase 4,Phase 3,Phase 2
47 Anti-Infective Agents Phase 4,Phase 3,Phase 2
48 Antimalarials Phase 4,Phase 2
49 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
50 Laxatives Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 55)

# Name Status NCT ID Phase Drugs
1 A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome Unknown status NCT00344721 Phase 4 Essential fatty acid supplement
2 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
3 Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Completed NCT01478256 Phase 4 Erythromycin;Besifloxocin
4 Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis Completed NCT01357538 Phase 4 Posiformin 2 %, bibrocathol;Placebo Comparator
5 Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis Completed NCT00629941 Phase 4 AzaSite®
6 Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis Completed NCT00656539 Phase 4 AzaSite®
7 Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis Completed NCT00629980 Phase 4 AzaSite®
8 Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis Completed NCT00629590 Phase 4 AzaSite®
9 Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis Completed NCT01456780 Phase 4 Loteprednol/tobramycin;Loteprednol;B+L Advanced Eye Relief Lubricant Drop
10 Lipids of the Human Tear Film and Their Effect on Tear Stability Completed NCT00803452 Phase 4 doxycycline;azithromycin
11 Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye Completed NCT00987727 Phase 4 carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD);sodium hyaluronate 0.18% (VISMED® Multi)
12 Zylet vs TobraDex in Blepharokeratoconjunctivitis Completed NCT00447577 Phase 4 Loteprednol etabonate and tobramycin ophthalmic suspension;Tobramycin and dexamethasone ophthalmic suspension
13 The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis Enrolling by invitation NCT03105505 Phase 4 Permethrin 5%;Synthomycine 5%;Fusidic Acid 1% M/R Eye Drops
14 A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis Completed NCT01102244 Phase 3 Tobradex ST;Azasite
15 Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Completed NCT02236403 Phase 3 Ivermectin 0.1% Metronidazole 1%
16 Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Completed NCT01408082 Phase 3 ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined);Azasite;Dexamethasone
17 Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis Completed NCT00732446 Phase 3 Moxifloxacin and Dexamethasone combined;Moxifloxacin;Dexamethasone
18 Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Completed NCT00796926 Phase 3 Systane Ultra eyedrops;Refresh eye drops
19 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Completed NCT01028027 Phase 3 Loteprednol and tobramycin;Tobramycin and dexamethasone
20 Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects Not yet recruiting NCT01543490 Phase 3 ISV-305
21 Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Withdrawn NCT01721694 Phase 3 azithromycin 1.5%/Loteprednol 0,5% + placebo;azithromycin 1.5% + Loteprednol 0,5% (separately)
22 Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. Unknown status NCT02300818 Phase 1, Phase 2 Seawater eyedrops
23 Oral Azithromycin Versus Doxycycline in Posterior Blepharitis Completed NCT01783860 Phase 2 Azithromycin;Doxycycline
24 Tea Tree Oil in the Treatment of Chronic Blepharitis Completed NCT01073150 Phase 2 Tea Tree Oil
25 Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Completed NCT01089608 Phase 2 Azithromycin;Povidone
26 Topical IL-1-Ra for Treatment of Posterior Blepharitis Completed NCT00681109 Phase 1, Phase 2 2.5% IL-1Ra;Placebo;5% IL-1Ra
27 Treatment of Patients With Blepharitis and Facial Rosacea Completed NCT00560703 Phase 2 COL-101 (doxycycline, USP) capsules;placebo
28 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period Completed NCT00892970 Phase 2 Azithromycin ophthalmic solution, 1%;Placebo
29 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Completed NCT00894530 Phase 2 Azithromycin ophthalmic solution, 1%;Placebo
30 Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Completed NCT02218489 Phase 2 KPI-121;Vehicle
31 Evaluation and Treatment of Eye Complications of Vaccinia Vaccination Completed NCT00081835 Phase 2 NP-016 Vaccine Immune Globulin (IV-VIG)
32 A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) Terminated NCT01269658 Phase 2 Azithromycin ophthalmic solution, 1%;Vehicle
33 A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641) Terminated NCT01220258 Phase 2 Azithromycin ophthalmic solution, 1%
34 A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates Terminated NCT00579020 Phase 2 Moxifloxacin/dexamethasone phosphate ophthalmic solution;Moxifloxacin ophthalmic solution 0.5%;Dexamethasone phosphate solution, 0.1%
35 Demodex Blepharitis Treatment Study Completed NCT01647217 Phase 1 Terpinen-4-ol
36 Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora Unknown status NCT02455895
37 Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma Unknown status NCT01284439 hydroxypropylmethylcellulose;sodium hyaluronate
38 Blephacura Versus Baby Shampoo to Treat Blepharitis Completed NCT01115192
39 Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery Completed NCT01808560
40 Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points Completed NCT00345241 Systane Ocular Drops (OTC);Placebo - Saline Drops
41 Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia Completed NCT01308333
42 The Effect of Meibomian Glands Massage on Signs and Symptoms of Dry Eye Completed NCT03104894
43 Evaluation and Treatment of Patients With Corneal and External Diseases Completed NCT00008541
44 Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate Completed NCT01692652 topical loteprednol etabonate (lotemax 0.5%) with warm compress & ocular massage
45 Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction Completed NCT01600625 oral minocycline hydrochloride treatment
46 Antimicrobial and Clinical Efficacy of Cliradex® as Compared With I-Lid'n Lash® Hygiene in Treating Blepharitis Recruiting NCT03422146
47 To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis Recruiting NCT03301844
48 Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis Recruiting NCT02952079
49 Ocular Comfort and Inflammation in Lid Hygiene Therapy Recruiting NCT02938078
50 Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa Recruiting NCT02386774

Search NIH Clinical Center for Blepharitis

Cochrane evidence based reviews: blepharitis

Genetic Tests for Blepharitis

Genetic tests related to Blepharitis:

# Genetic test Affiliating Genes
1 Blepharitis 28

Anatomical Context for Blepharitis

MalaCards organs/tissues related to Blepharitis:

38
Eye, Skin, Testes

Publications for Blepharitis

Articles related to Blepharitis:

(show top 50) (show all 266)
# Title Authors Year
1
Satisfaction and convenience of using terpenoid-impregnated eyelid wipes and teaching method in people without blepharitis. ( 29379270 )
2018
2
Development and evaluation of a measure of patient-reported symptoms of Blepharitis. ( 29325546 )
2018
3
Randomized double-masked trial of eyelid cleansing treatments for blepharitis. ( 29128682 )
2018
4
The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis. ( 29074306 )
2018
5
Blepharitis With Facial Numbness and Ocular Pain. ( 28880989 )
2017
6
Unilateral Blepharitis With Fine Follicular Scaling. ( 28920471 )
2017
7
The association of keratoconus with blepharitis. ( 29232760 )
2017
8
Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report. ( 28643231 )
2017
9
Meibography for eyes with posterior blepharitis. ( 28860908 )
2017
10
Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: a nationwide population-based cohort study. ( 28183148 )
2017
11
Preclinical development of MGO Manuka Honey microemulsion for blepharitis management. ( 29354709 )
2017
12
Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study. ( 29146760 )
2017
13
Tacrolimus Ointment for Refractory Posterior Blepharitis. ( 28922018 )
2017
14
Retraction of: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment; DOI: 10.1089/jop.2015.0099. ( 28605219 )
2017
15
Blepharitis ( 29083763 )
2017
16
High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff. ( 28552438 )
2017
17
Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis. ( 29354710 )
2017
18
DEBS - a unification theory for dry eye and blepharitis. ( 28003734 )
2016
19
Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis. ( 27500111 )
2016
20
Oral azithromycin and blepharitis: symptoms and signs improve, so where are the publications? ( 27356302 )
2016
21
Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis. ( 26788833 )
2016
22
Meibomian gland dysfunction: azithromycin and objective improvement in outcomes in posterior blepharitis. ( 27314917 )
2016
23
Demodex folliculorum: Following the trail to chronic blepharitis. ( 26775083 )
2016
24
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis. ( 27570444 )
2016
25
Recurrent Fungal Keratitis and Blepharitis Caused by Aspergillus flavus. ( 27621301 )
2016
26
Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis. ( 27349766 )
2016
27
The Effect of Demodex Infestation on Blepharitis and the Ocular Symptoms. ( 26783981 )
2016
28
Blepharitis: remains a diagnostic enigma. A role for tea tree oil shampoo? ( 26293141 )
2015
29
Comparative study of the efficacy of different treatment options in patients with chronic blepharitis. ( 25542616 )
2015
30
Periodic acid-Schiff staining demonstrates fungi in chronic anterior blepharitis. ( 26293142 )
2015
31
Treatment Options for Demodex Blepharitis: Patient Choice and Efficacy. ( 25902082 )
2015
32
Medical management of blepharitis. ( 26058027 )
2015
33
Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study. ( 26068735 )
2015
34
Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis. ( 26347811 )
2015
35
WITHDRAWN: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment. ( 26717146 )
2015
36
Common Blepharitis Related to Phthiriasis Palpebrarum: Argon Laser Phototherapy. ( 26470938 )
2015
37
Cheek and periorbital peculiar discoid lupus erythematosus: rare clinical presentation mimicking tinea faciei, cutaneous granulomatous disease or blepharitis. ( 25969679 )
2015
38
Acute blepharitis: an unusual complication of zoledronic acid. ( 26412501 )
2015
39
Herpes simplex virus blepharitis in a patient with Crohn's colitis. ( 24613714 )
2014
40
Malassezia spp on the periocular skin of dogs and their association with blepharitis, ocular discharge, and the application of ophthalmic medications. ( 24846431 )
2014
41
Staphylococcus aureus Blepharitis Associated with Multiple Corneal Stromal Microabscess, Stromal Edema, and Uveitis. ( 24410378 )
2014
42
Intraductal meibomian gland probing for the treatment of blepharitis. ( 25001110 )
2014
43
Ocular rosacea: an underdiagnosed cause of relapsing conjunctivitis-blepharitis in the elderly. ( 25239991 )
2014
44
Treatment of blepharitis: recent clinical trials. ( 25284773 )
2014
45
Blepharitis: always remember demodex. ( 25371637 )
2014
46
Two cases of tinea ciliaris with blepharitis due to Microsporum audouinii and Trichophyton verrucosum and review of the literature. ( 24724801 )
2014
47
STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis. ( 24845637 )
2014
48
Assessment of the tolerability profile of an ophthalmic solution of 5% glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy in the treatment of moderate to severe blepharitis. ( 23874081 )
2013
49
Assessment of signs of anterior blepharitis using standardized color photographs. ( 24055901 )
2013
50
Demodex blepharitis mimicking eyelid sebaceous gland carcinoma. ( 23565576 )
2013

Variations for Blepharitis

Expression for Blepharitis

Search GEO for disease gene expression data for Blepharitis.

Pathways for Blepharitis

GO Terms for Blepharitis

Biological processes related to Blepharitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.26 CRYAA IL4 LACRT MMP9
2 positive regulation of release of cytochrome c from mitochondria GO:0090200 9.16 MMP9 PLA2G6
3 chemotaxis GO:0006935 8.8 CCL11 IL4 PLA2G6

Sources for Blepharitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....